Nano-Drug Delivery Systems Based on Natural Products
Ying Lv,Wenqing Li,Wei Liao,Haibo Jiang,Yuwei Liu,Jiansheng Cao,Wenfei Lu,Yufei Feng
DOI: https://doi.org/10.2147/ijn.s443692
IF: 7.033
2024-01-19
International Journal of Nanomedicine
Abstract:Ying Lv, Wenqing Li, Wei Liao, Haibo Jiang, Yuwei Liu, Jiansheng Cao, Wenfei Lu, Yufei Feng Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, 150040, People's Republic of China Correspondence: Yufei Feng, 150040, Tel +86-18503653988, Email Natural products have proven to have significant curative effects and are increasingly considered as potential candidates for clinical prevention, diagnosis, and treatment. Compared with synthetic drugs, natural products not only have diverse structures but also exhibit a range of biological activities against different disease states and molecular targets, making them attractive for development in the field of medicine. Despite advancements in the use of natural products for clinical purposes, there remain obstacles that hinder their full potential. These challenges include issues such as limited solubility and stability when administered orally, as well as short durations of effectiveness. To address these concerns, nano-drug delivery systems have emerged as a promising solution to overcome the barriers faced in the clinical application of natural products. These systems offer notable advantages, such as a large specific surface area, enhanced targeting capabilities, and the ability to achieve sustained and controlled release. Extensive in vitro and in vivo studies have provided further evidence supporting the efficacy and safety of nanoparticle-based systems in delivering natural products in preclinical disease models. This review describes the limitations of natural product applications and the current status of natural products combined with nanotechnology. The latest advances in nano-drug delivery systems for delivery of natural products are considered from three aspects: connecting targeting warheads, self-assembly, and co-delivery. Finally, the challenges faced in the clinical translation of nano-drugs are discussed. Keywords: natural products, nanotechnology, drug delivery, targeting Graphical Over the course of human evolution, natural products have been a source of necessities for human life. They have been used in numerous fields, ranging from ancient applications in paper-making to modern use in the production of perfumes and spices, and recently for the precaution and treatment of diverse diseases. 1,2 With the continued advances in separation techniques and methods for evaluating pharmacological effects, an increasing number of active components have been identified in natural products. Due to the structural diversity of natural products and their biological activities on multiple tissues and molecular targets, modulating various signaling or functional pathways, they have significant clinical applications, especially in the treatment of complex diseases such as cancer and cardiovascular disorders. 3,4 The effectiveness of natural products in clinical trials, however, has not been particularly impressive, and most pharmaceutical companies are currently reluctant to pursue their development. 5–7 This is mainly due to concerns regarding their poor solubility, limited biological distribution, or rapid metabolic clearance. These factors may result in drug plasma concentrations falling below therapeutic levels. Additionally, permeability and absorption across biological membranes and barriers can be challenging for compounds with relatively high molecular weight and low lipophilicity, resulting in poor drug transport efficiency and short half-lives. Therefore, finding new drug delivery methods may provide solutions to address these key issues. 8,9 Currently, identifying the most effective means to maximize the efficacy of natural products is an important focus of research in the scientific community. These studies will lead to the emergence of more innovative drugs with fewer side effects. 10 Nanotechnology has proven to be instrumental in connecting the realms of biological and physical sciences. Specifically, nano-drug delivery systems have garnered considerable interest within the pharmaceutical industry. 7,11,12 Carriers based on nanostructures can facilitate drug delivery by encapsulating or attaching therapeutic agents and precisely targeting tissues or organs through controlled release. 9,13 Compared to larger materials, nano-drugs designed at the atomic or molecular level have the ability to move more unrestrictedly within the human body, thus enabling them to attain therapeutic effects. 14–19 However, the scope of application of these methods has huge limitations compared to the delivery of drugs through nanostructures. Drug delivery systems based on nanoparticles (NPs) not only improve the mean residence times of drugs in the body, but also have unique advantag -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology